Gorman Reynolds, MD
Gastroenterology · Morgantown, WVNPI 1184750325
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,838 and has fallen 65.3% since, to $639 in 2025.
Across 196 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$631
- Takeda Pharmaceuticals U.S.A., Inc.$484
- Johnson & Johnson$449
- Pfizer$374
- Sanofi$327
- Nestle Healthcare Nutrition Inc.$314
- plus $1K from 22 others
Across 124 payments — averaging $3063.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$282K
- Gilead$90K
- Bristol Myers Squibb$6K
- Pfizer$1K
What the payments were for
- Food & beverage$3,86999%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $631 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $484 |
| Johnson & Johnson | 16 | $449 |
| Pfizer | 23 | $374 |
| Sanofi | 13 | $327 |
| Nestle Healthcare Nutrition Inc. | 2 | $314 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $302 |
| Bristol Myers Squibb | 9 | $154 |
| Ipsen Biopharmaceuticals, Inc | 5 | $138 |
| Boehringer Ingelheim | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Ardelyx, Inc. | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 5 | $75 |
| Merck | 3 | $60 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| 3-d Matrix, Inc. | 1 | $39 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
| UCB, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Celltrion USA Inc. | 1 | $28 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| Creo Medical Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $19 |
| QOL Medical, LLC | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$314
How this compares
$3,900 in reported general payments places this provider in the 65th percentile of 72 gastroenterology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 21 | $8,532 |
| Budesonide EcBudesonide | 13 | $2,140 |
| Pantoprazole Sodium | 164 | $1,318 |
| Omeprazole | 130 | $1,036 |
| Budesonide DrBudesonide | 13 | $821 |
| Sucralfate | 26 | $752 |
| Dicyclomine Hcl | 20 | $281 |
| Spironolactone | 11 | $269 |
| Cyclobenzaprine Hcl | 11 | $251 |
| Celecoxib | 11 | $156 |
| Famotidine | 13 | $84 |
| Ondansetron Hcl | 14 | $56 |
| Gabapentin | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Morgantown
- Jennifer VeverkaMorgantown$283K
- Shailendra SinghMorgantown$187K
- Shyam ThakkarMorgantown$113K
- John NasrMorgantown$30K
- Matthew KrafftMorgantown$28K
- Yousaf HadiMorgantown$13K
- Anshu MahajanMorgantown$4K
- Alyssa LorenzeMorgantown$1K
- William HutsonMorgantown$1K
- Monica ChowdhryMorgantown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.